How to taper off Xanax (alprazolam) 2.5mg/day and switch to Clonazepam (clonazepam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tapering Alprazolam and Switching to Clonazepam

The safest approach to taper off Xanax (alprazolam) 2.5mg/day and switch to clonazepam is to substitute clonazepam and then gradually reduce the dose by 25% every 1-2 weeks to minimize withdrawal symptoms. 1, 2

Initial Substitution Phase

  • Convert from alprazolam to clonazepam using an appropriate equivalence ratio. For alprazolam 2.5mg daily, substitute with approximately 2.5mg of clonazepam (1:1 equivalence ratio is commonly used for these two potent benzodiazepines) 3
  • Divide the daily clonazepam dose into 2-3 administrations per day initially to maintain stable blood levels 3
  • Monitor for 24-48 hours after substitution to ensure adequate symptom control and adjust dosing if needed 1

Tapering Schedule

  • Once stabilized on clonazepam, begin a gradual taper by reducing the dose by 25% every 1-2 weeks 1
  • For a 2.5mg starting dose of clonazepam, a sample tapering schedule would be:
    • Weeks 1-2: 2.5mg daily
    • Weeks 3-4: 1.875mg daily
    • Weeks 5-6: 1.4mg daily
    • Weeks 7-8: 1.05mg daily
    • Weeks 9-10: 0.75mg daily
    • Weeks 11-12: 0.5mg daily
    • Weeks 13-14: 0.25mg daily
    • Then discontinue 1

Monitoring and Adjustments

  • Assess for withdrawal symptoms at each dose reduction using standardized assessment tools 1
  • Common withdrawal symptoms include anxiety, insomnia, irritability, tremor, headache, nausea, and sensory hypersensitivity 2
  • More severe withdrawal symptoms may include seizures, hallucinations, and delirium tremens 2
  • If significant withdrawal symptoms occur, maintain the current dose for an additional week before attempting further reduction 1

Adjunctive Treatments

  • Consider cognitive-behavioral therapy (CBT) during the taper, as it increases tapering success rates 1, 4
  • For anxiety symptoms during tapering, non-benzodiazepine treatments such as specific antidepressants may be considered 1
  • Implement sleep hygiene measures and possibly non-benzodiazepine sleep aids if insomnia becomes problematic 1

Important Considerations and Cautions

  • Never abruptly discontinue alprazolam or clonazepam as this can lead to severe withdrawal including seizures, hallucinations, and in rare cases, death 2, 1
  • The taper may need to be slower (10% reduction every 2-4 weeks) for patients who have been on high doses for extended periods 5
  • Clonazepam's longer half-life (19-41 hours) compared to alprazolam makes it advantageous for tapering as it provides more stable blood levels and less severe interdose withdrawal 2
  • If the patient is also taking opioids, coordinate care with all prescribers due to the increased risk of respiratory depression with concurrent use 1
  • For patients struggling with the taper, slower reduction rates may be necessary, potentially extending the taper over several months 6
  • Communicate with mental health professionals managing the patient to coordinate care and address underlying anxiety disorders 1

Special Situations

  • For patients with a history of seizures or severe withdrawal symptoms, consider inpatient monitoring during the initial substitution phase 5
  • For elderly patients or those with hepatic impairment, use lower initial doses of clonazepam and taper more gradually 7
  • If withdrawal symptoms become intolerable despite slow tapering, temporarily increasing the dose to the previous level and then resuming a more gradual taper may be necessary 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Detoxification from benzodiazepines: schedules and strategies.

Journal of substance abuse treatment, 1991

Research

Treating Benzodiazepine Withdrawal in a Bridge Clinic.

Journal of addiction medicine, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.